{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:56:54Z","timestamp":1785405414298,"version":"3.56.0"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006377","name":"Purdue University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013415","name":"Purdue University Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA023168"],"award-info":[{"award-number":["P30 CA023168"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chemoimmunotherapy leverages the immune system to control tumor growth and develop durable antitumor immunity. With this goal, we previously developed a nanoparticulate immunoactive complex (IMAX), composed of polyethyleneimine\u2013lithocholic acid conjugate, paclitaxel, and a cyclic dinucleotide, which showed robust antitumor activity in multiple mouse models following intratumoral administration. In this study, we evaluated the biodistribution of locally delivered IMAX and determined a safe and effective dose in mice to inform pilot safety and efficacy evaluations in dogs. In mice, IMAX remained localized at the injection site with minimal systemic exposure, induced rapid immune cell infiltration, evidenced by gross skin reactions and histologic changes, and achieved complete tumor regression even at one-fifth of the initial dose. Laboratory dogs tolerated IMAX well, with only transient, manageable adverse events. In a pilot study in companion dogs with naturally occurring cancer, IMAX administered at conservative doses induced histologic changes indicating immune cell infiltration and necrosis, accompanied by transcriptomic signatures of early innate immune pathway activation, resulting in measurable antitumor effects in the dogs with mammary carcinoma. These findings support the feasibility and safety of local IMAX therapy in tumor-bearing dogs and warrant further investigation with optimized dosing and combination strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Locally administered nanoparticulate IMAX induces complete tumor regression in mice and triggers rapid immune cell infiltration, while producing measurable antitumor responses in companion dogs with mammary carcinoma, supporting the translational potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0110","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:45:08Z","timestamp":1780040708000},"page":"1455-1469","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanoparticulate Immunoactive Complex for Local Chemoimmunotherapy: From Murine Models to Pilot Canine Study"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3934-5922","authenticated-orcid":false,"given":"Yanying","family":"He","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 1 Department of Industrial and Molecular Pharmaceutics, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9843-5371","authenticated-orcid":false,"given":"Jiaqi","family":"Zhao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 1 Department of Industrial and Molecular Pharmaceutics, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6235-3157","authenticated-orcid":false,"given":"Jung Suk","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 1 Department of Industrial and Molecular Pharmaceutics, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-1616","authenticated-orcid":false,"given":"Meaghan M.","family":"Broman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 2 Department of Comparative Pathobiology, College of Veterinary Medicine, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3049-0103","authenticated-orcid":false,"given":"Simone","family":"de Brot","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02k7v4d05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Bern 3 Institute of Animal Pathology, COMPATH, , Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-7888","authenticated-orcid":false,"given":"Fanfei","family":"Meng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 1 Department of Industrial and Molecular Pharmaceutics, , West Lafayette, Indiana."},{"name":"4Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5456-9302","authenticated-orcid":false,"given":"Deepika","family":"Dhawan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 5 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-1948","authenticated-orcid":false,"given":"Sagar M.","family":"Utturkar","sequence":"additional","affiliation":[{"name":"6Purdue University Institute for Cancer Research, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3431-6065","authenticated-orcid":false,"given":"Marejka H.","family":"Shaevitz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 5 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, , West Lafayette, Indiana."},{"name":"6Purdue University Institute for Cancer Research, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1075-8614","authenticated-orcid":false,"given":"Lindsey M.","family":"Fourez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 5 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0059-0202","authenticated-orcid":false,"given":"Deborah W.","family":"Knapp","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 5 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, , West Lafayette, Indiana."},{"name":"6Purdue University Institute for Cancer Research, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-7701","authenticated-orcid":false,"given":"Yoon","family":"Yeo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 1 Department of Industrial and Molecular Pharmaceutics, , West Lafayette, Indiana."},{"name":"6Purdue University Institute for Cancer Research, West Lafayette, Indiana."},{"id":[{"id":"https:\/\/ror.org\/02dqehb95","id-type":"ROR","asserted-by":"publisher"}],"name":"Purdue University 7 Weldon School of Biomedical Engineering, , West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026062207240638200_bib1","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"2026062207240638200_bib2","doi-asserted-by":"crossref","first-page":"e2122595119","DOI":"10.1073\/pnas.2122595119","article-title":"A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity","volume":"119","author":"Meng","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062207240638200_bib3","first-page":"4355","article-title":"Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase","volume":"54","author":"Long","year":"1994","journal-title":"Cancer Res"},{"key":"2026062207240638200_bib4","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/acsnano.3c11445","article-title":"Systemic delivery of paclitaxel by find-me nanoparticles activates antitumor immunity and eliminates tumors","volume":"18","author":"Kwon","year":"2024","journal-title":"ACS Nano"},{"key":"2026062207240638200_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2026062207240638200_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fimmu.2020.00615","article-title":"Research advances in how the cGAS-STING pathway controls the cellular inflammatory response","volume":"11","author":"Wan","year":"2020","journal-title":"Front Immunol"},{"key":"2026062207240638200_bib7","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS\u2013STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat Cancer"},{"key":"2026062207240638200_bib8","doi-asserted-by":"crossref","first-page":"113579","DOI":"10.1016\/j.jconrel.2025.02.075","article-title":"Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor","volume":"381","author":"Meng","year":"2025","journal-title":"J Control Release"},{"key":"2026062207240638200_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-animal-022114-110911","article-title":"Dogs as a model for cancer","volume":"4","author":"Gardner","year":"2016","journal-title":"Annu Rev Anim Biosci"},{"key":"2026062207240638200_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.pmbts.2021.12.003","article-title":"Canine models of human cancer: bridging the gap to improve precision medicine","volume":"189","author":"Nance","year":"2022","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2026062207240638200_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-017-4548-2","article-title":"Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors","volume":"167","author":"Nguyen","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2026062207240638200_bib12","doi-asserted-by":"crossref","first-page":"106055","DOI":"10.1016\/j.tvjl.2023.106055","article-title":"Profiling canine mammary tumors: a potential model for studying human breast cancer","volume":"303","author":"Gherman","year":"2024","journal-title":"Vet J"},{"key":"2026062207240638200_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2023.26.e4","article-title":"Canine as a comparative and translational model for human mammary tumor","volume":"26","author":"Kwon","year":"2023","journal-title":"J Breast Cancer"},{"key":"2026062207240638200_bib14","first-page":"8195","article-title":"Canine mammary tumors as a model for human disease","volume":"15","author":"Abdelmegeed","year":"2018","journal-title":"Oncol Lett"},{"key":"2026062207240638200_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pharmthera.2018.01.012","article-title":"Canine sarcomas as a surrogate for the human disease","volume":"188","author":"Gustafson","year":"2018","journal-title":"Pharmacol Ther"},{"key":"2026062207240638200_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcpa.2014.09.005","article-title":"Comparative pathology of canine soft tissue sarcomas: possible models of human non-rhabdomyosarcoma soft tissue sarcomas","volume":"152","author":"Milovancev","year":"2015","journal-title":"J Comp Pathol"},{"key":"2026062207240638200_bib17","doi-asserted-by":"crossref","first-page":"1130215","DOI":"10.3389\/fonc.2023.1130215","article-title":"Naturally occurring canine sarcomas: bridging the gap from mouse models to human patients through cross-disciplinary research partnerships","volume":"13","author":"Klosowski","year":"2023","journal-title":"Front Oncol"},{"key":"2026062207240638200_bib18","first-page":"362","article-title":"A review on canine and human soft tissue sarcomas: new insights on prognosis factors and treatment measures","volume":"11","author":"Dell\u2019Anno","year":"2024","journal-title":"Vet Sci"},{"key":"2026062207240638200_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/vco.12677","article-title":"Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats","volume":"19","author":"LeBlanc","year":"2021","journal-title":"Vet Comp Oncol"},{"key":"2026062207240638200_bib20","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026062207240638200_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/vco.12032","article-title":"Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document","volume":"13","author":"Nguyen","year":"2015","journal-title":"Vet Comp Oncol"},{"key":"2026062207240638200_bib22","doi-asserted-by":"crossref","first-page":"gkaf018","DOI":"10.1093\/nar\/gkaf018","article-title":"edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets","volume":"53","author":"Chen","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"2026062207240638200_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2026062207240638200_bib24","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1538-7445.AM2021-1693","article-title":"Abstract 1693: multi-national, multi-center collaboration to develop a novel gene expression tool for comparative translational immuno-oncology","volume":"81","author":"Mason","year":"2021","journal-title":"Cancer Res"},{"key":"2026062207240638200_bib25","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1158\/1535-7163.MCT-20-0893","article-title":"Phase I\/II trial of vemurafenib in dogs with naturally occurring, BRAF-mutated urothelial carcinoma","volume":"20","author":"Rossman","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2026062207240638200_bib26","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/0008-5472.CAN-04-0752","article-title":"Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function","volume":"64","author":"Isaka","year":"2004","journal-title":"Cancer Res"},{"key":"2026062207240638200_bib27","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"2026062207240638200_bib28","first-page":"68","article-title":"Comparative study of cytokine measurements in blood plasma and serum, and saliva of juvenile pigs during experimentally induced acute inflammation","volume":"13","author":"Madsen","year":"2026","journal-title":"Vet Sci"},{"key":"2026062207240638200_bib29","doi-asserted-by":"crossref","first-page":"E874","DOI":"10.1073\/pnas.1521359113","article-title":"Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis","volume":"113","author":"Brackett","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062207240638200_bib30","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.apsb.2021.04.019","article-title":"Salmonella flagella confer anti-tumor immunological effect via activating Flagellin\/TLR5 signalling within tumor microenvironment","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"2026062207240638200_bib31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"2026062207240638200_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/23328940.2015.1102802","article-title":"Central mediators involved in the febrile response: effects of antipyretic drugs","volume":"2","author":"Zampronio","year":"2015","journal-title":"Temperature (Austin)"},{"key":"2026062207240638200_bib33","doi-asserted-by":"crossref","first-page":"1485546","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"2026062207240638200_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0300985812447830","article-title":"Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics","volume":"50","author":"Pe\u00f1a","year":"2013","journal-title":"Vet Pathol"},{"key":"2026062207240638200_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0300985810388820","article-title":"Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs","volume":"48","author":"Dennis","year":"2011","journal-title":"Vet Pathol"},{"key":"2026062207240638200_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/17425247.2010.485983","article-title":"Cationic nanoparticles for cancer therapy","volume":"7","author":"Bilensoy","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"2026062207240638200_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in gene therapy: current status and clinical applications","volume":"362","author":"Casper","year":"2023","journal-title":"J Control Release"},{"key":"2026062207240638200_bib38","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.gt.3301516","article-title":"Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes","volume":"8","author":"Oh","year":"2001","journal-title":"Gene Ther"},{"key":"2026062207240638200_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/00031348211023434","article-title":"Surgical resection after talimogene laherparepvec for melanoma: persistent fuorodeoxyglucose avidity on positron emission tomography despite no viable disease","volume":"87","author":"MacArthur","year":"2021","journal-title":"The Am Surgeon"},{"key":"2026062207240638200_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4049\/jimmunol.1601145","article-title":"Intratumoral delivery of immunotherapy-act locally, think globally","volume":"198","author":"Aznar","year":"2017","journal-title":"J Immunol"},{"key":"2026062207240638200_bib41","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","article-title":"Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel","volume":"4","author":"Wang","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"2026062207240638200_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biomaterials.2018.01.035","article-title":"STINGel: controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy","volume":"163","author":"Leach","year":"2018","journal-title":"Biomaterials"},{"key":"2026062207240638200_bib43","doi-asserted-by":"crossref","first-page":"2001056","DOI":"10.1002\/adhm.202001056","article-title":"Amphiphilic polyelectrolyte graft copolymers enhance the activity of cyclic dinucleotide STING agonists","volume":"10","author":"Nguyen","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"2026062207240638200_bib44","doi-asserted-by":"crossref","first-page":"eaaz6606","DOI":"10.1126\/scitranslmed.aaz6606","article-title":"Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy","volume":"12","author":"Lu","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026062207240638200_bib45","doi-asserted-by":"crossref","first-page":"114410","DOI":"10.1016\/j.jconrel.2025.114410","article-title":"Controlled delivery of STING agonist and manganese ion in injectable PLGA implants for enhanced cancer immunotherapy","volume":"389","author":"Kodamasimham","year":"2026","journal-title":"J Control Release"},{"key":"2026062207240638200_bib46","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1073\/pnas.1512832112","article-title":"STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity","volume":"112","author":"Demaria","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062207240638200_bib47","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3389\/fimmu.2020.02090","article-title":"Tumor-derived cGAMP regulates activation of the vasculature","volume":"11","author":"Campisi","year":"2020","journal-title":"Front Immunol"},{"key":"2026062207240638200_bib48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1535-7163.MCT-24-0317","article-title":"Preclinical evaluation of an anchored immunotherapy strategy with aluminum hydroxide-tethered IL-12 in dogs with advanced malignant melanoma","volume":"24","author":"Passos Barbosa","year":"2025","journal-title":"Mol Cancer Ther"},{"key":"2026062207240638200_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/vco.12813","article-title":"Developing a translational murine-to-canine pathway for an IL-2\/agonist anti-CD40 antibody cancer immunotherapy","volume":"20","author":"Proksch","year":"2022","journal-title":"Vet Comp Oncol"},{"key":"2026062207240638200_bib50","first-page":"327","article-title":"Safety and efficacy of an oncolytic adenovirus as an immunotherapy for canine cancer patients","volume":"9","author":"Mart\u00edn-Carrasco","year":"2022","journal-title":"Vet Sci"},{"key":"2026062207240638200_bib51","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1021\/acs.molpharmaceut.5c00100","article-title":"Pilot study of intratumoral immunotherapy with cowpea mosaic virus nanoparticles: safety in refractory canine oral tumors","volume":"22","author":"Delgado-Bonet","year":"2025","journal-title":"Mol Pharm"},{"key":"2026062207240638200_bib52","doi-asserted-by":"crossref","first-page":"e002688","DOI":"10.1136\/jitc-2021-002688","article-title":"Simple and effective bacterial-based intratumoral cancer immunotherapy","volume":"9","author":"Carroll","year":"2021","journal-title":"J Immunother Cancer"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0110\/3799529\/crc-26-0110.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1455\/3804977\/crc-26-0110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1455\/3804977\/crc-26-0110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:24:23Z","timestamp":1782127463000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/6\/1455\/785970\/Nanoparticulate-Immunoactive-Complex-for-Local"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0110","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32759078","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759123","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759111","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759114","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759102","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759105","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759117","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759081","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759093","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759072","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759084","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759096","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759075","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759087","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759120","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759099","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759090","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32759108","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8551025","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}